Combined modality approach of locally advanced breast cancer with conservative surgery
Journal of the Egyptian National Cancer Institute. 1995; 7 (1): 123-130
in English
| IMEMR
| ID: emr-106363
ABSTRACT
One hundred and eleven patients with noninflammatory locally advanced breast cancer [LABC] stage IIIA and B [T3-4b, No-2] were treated. Patients were randomized into two groups The study group A [61 patients] and the control group B [50 patients]. Patients of group A received three cycles [FAC] neoadjuvant chemotherapy [NCT] [5- fluorouracil 500 mg/m2, adriamycin 50 mg/m2 and cyclophosphamide 500 mg/m2, every three weeks]. Lumpectomy and axillary dissection [LAD] were performed for patients achieving downstaging to /
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Clinical Trials as Topic
/
Chemotherapy, Adjuvant
Type of study:
Controlled clinical trial
Limits:
Female
/
Humans
Language:
English
Journal:
J. Egypt. Natl. Cancer Inst.
Year:
1995
Similar
MEDLINE
...
LILACS
LIS